<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>Search:  "cardiac" AND "gene therapy" <a href="https://journal-scrape.herokuapp.com/-cardiac-and-gene-therapy.html">(See all results)</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: XPO1 gene therapy restores cardiac function in rats with chronic induced myocardial infarction</h4><p><a href="https://www.biorxiv.org/content/10.1101/575340v1">Link</a></p><p><b>Date:</b> 2019-03-12</p><p><b>Authors:</b> María García-Manzanares ... Miguel Rivera</p><p><b>Downloads:</b> 167</p></div><div class="everything-else"><p><b>Abstract:</b> Background: In previous studies, we showed that several nuclear-cytoplasmic transport molecules were closely related to ventricular dysfunction in human heart failure.  Particularly, the transcriptomic signature of XPO1 was highly expressed and inversely related to left ventricular function in heart failure patients of ischemic etiology.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31981894">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Caitlin J Lewis ...  Amutha Boominathan</p><p><b>IF (7 or above):</b> 7.77</p></div><div class="everything-else"><p><b>Abstract:</b> Mutations in mitochondrial DNA can be inherited or occur de novo leading to several debilitating myopathies with no curative option and few or no effective treatments.  Allotopic expression of recoded mitochondrial genes from the nucleus has potential as a gene therapy strategy for such conditions,  ....</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State</h4><p><a href="https://www.biorxiv.org/content/10.1101/801092v1">Link</a></p><p><b>Date:</b> 2019-10-10</p><p><b>Authors:</b> Thomas Kisby ... Kostas Kostarelos</p><p><b>Downloads:</b> 416</p></div><div class="everything-else"><p><b>Abstract:</b> Zebrafish and urodele amphibians are capable of extraordinary myocardial regeneration thanks to the ability of their cardiomyocytes to undergo transient dedifferentiation and proliferation.  Somatic cells can be temporarily reprogrammed to a proliferative, dedifferentiated state through transient expression of Oct3/4, Sox2, Klf4 and c-Myc (OSKM) transcription factors.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Preclinical development of a miR-132 inhibitor for heart failure treatment.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32005803">Link</a></p><p><b>Date:</b> 2020-02-01</p><p><b>Authors:</b> Ariana Foinquinos ...  Thomas Thum</p><p><b>IF (7 or above):</b> 11.8</p></div><div class="everything-else"><p><b>Abstract:</b> Despite proven efficacy of pharmacotherapies targeting primarily global neurohormonal dysregulation, heart failure (HF) is a growing pandemic with increasing burden.  Treatments mechanistically focusing at the cardiomyocyte level are lacking.</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs</h4><p><a href="https://www.biorxiv.org/content/10.1101/699975v3">Link</a></p><p><b>Date:</b> 2019-07-11</p><p><b>Authors:</b> Daniel R Stroik ... David D. Thomas</p><p><b>Downloads:</b> 205</p></div><div class="everything-else"><p><b>Abstract:</b> There is increasing momentum toward the development of gene therapy for heart failure (HF), cardiomyopathy, and other progressive cardiac diseases that correlate with impaired calcium (Ca2+) transport and reduced contractility.  We have used FRET between fluorescently-tagged SERCA2a (the cardiac Ca2+ pump) and PLB (its ventricular peptide regulator) to directly test the effectiveness of loss-of-function/gain-of-binding PLB mutants (PLBM) that were engineered to compete with the binding of inhibitory wild type PLB (PLBWT).</p></div></td><td><div class="everything-else"><h4 class="title">Title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31902369">Link</a></p><p><b>Date:</b> 2020-01-06</p><p><b>Authors:</b> Xiumeng Hua ...  Jiangping Song</p><p><b>IF (7 or above):</b> 8.41</p></div><div class="everything-else"><p><b>Abstract:</b> BACKGROUND: Heart failure (HF) has been recognized as a global pandemic with a high rate of hospitalization, morbidity, and mortality.  Although numerous advances have been made, its representative molecular signatures remain largely unknown, especially the role of genes in HF progression.</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Exploring Mechanisms of Inhibition of Amyloid Seeding of Transthyretin</h4><p><a href="https://www.biorxiv.org/content/10.1101/354720v1">Link</a></p><p><b>Date:</b> 2018-06-28</p><p><b>Authors:</b> Lorena Saelices ... David S. Eisenberg</p><p><b>Downloads:</b> 448</p></div><div class="everything-else"><p><b>Abstract:</b> Amyloid deposition of the hormone transporter transthyretin causes familial and sporadic amyloidoses.  The current treatment for familial cases is gene-therapy by liver transplantation.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Nanoparticle-based Cell Trackers for Biomedical Applications.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32042345">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Jen-Shyang Ni ...  Kai Li</p><p><b>IF (7 or above):</b> 8.02</p></div><div class="everything-else"><p><b>Abstract:</b> The continuous or real-time tracking of biological processes using biocompatible contrast agents over a certain period of time is vital for precise diagnosis and treatment, such as monitoring tissue regeneration after stem cell transplantation, understanding the genesis, development, invasion and me ....</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Impaired Regulation of Redox Transcriptome during the Differentiation of iPSCs into Induced Cardiomyocytes (iCMs)</h4><p><a href="https://www.biorxiv.org/content/10.1101/519793v1">Link</a></p><p><b>Date:</b> 2019-01-14</p><p><b>Authors:</b> Gobinath Shanmugam ... Namakkal S. Rajasekaran</p><p><b>Downloads:</b> 293</p></div><div class="everything-else"><p><b>Abstract:</b> Background: Reprogramming of somatic cells into pluripotent stem cells (iPSC) and subsequent differentiation into iPSC-derived cardiomyocytes (iCM) seems to be a promising strategy for cardiac regenerative therapy.  However, recent failure or poor outcomes in cardiac cell therapy warrants further investigation focusing on the infarction/wound environment (site of healing) to improve the cardiac regenerative medicine.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Modulating the cobalt dose range to manipulate multisystem cooperation in bone environment: a strategy to resolve the controversies about cobalt use for orthopedic applications.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31938052">Link</a></p><p><b>Date:</b> 2020-01-15</p><p><b>Authors:</b> Guanqi Liu ...  Zetao Chen</p><p><b>IF (7 or above):</b> 8.02</p></div><div class="everything-else"><p><b>Abstract:</b> The paradoxical effect of cobalt on biological processes has aroused controversy regarding the application of cobalt-based biomaterials in bone regeneration.  Tuning the dose range of cobalt ions may be a valid strategy to resolve the controversies about cobalt use for orthopedic applications.</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Rapid pacing by circulating traveling waves improves maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring</h4><p><a href="https://www.biorxiv.org/content/10.1101/717108v1">Link</a></p><p><b>Date:</b> 2019-07-27</p><p><b>Authors:</b> Junjun Li ... Li Liu</p><p><b>Downloads:</b> 215</p></div><div class="everything-else"><p><b>Abstract:</b> Directed differentiation methods allow acquisition of high-purity cardiomyocytes (CMs) differentiated from human induced pluripotent stem cells (hiPSCs); however, their immaturity characteristic limits their application for drug screening and regenerative therapy.  The rapid electrical pacing of cardiomyocytes have been used for efficiently promoting the maturation of cardiomyocytes, here we describe a simple device in modified culture plate on which hiPSC-derived CMs (hiPSC-CMs) can form three-dimensional self-organized tissue rings (SOTRs).</p></div></td><td><div class="everything-else"><h4 class="title">Title: Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31986467">Link</a></p><p><b>Date:</b> 2020-01-27</p><p><b>Authors:</b> Xinyu Yang ...  Yanwei Xing</p><p><b>IF (7 or above):</b> 7.77</p></div><div class="everything-else"><p><b>Abstract:</b> Atrial fibrillation (AF) occurs in up to 11% of cancer patients treated with ibrutinib.  The pathophysiology of ibrutinib promoted AF is complicated, as there are multiple interactions involved; the detailed molecular mechanisms underlying this are still unclear.</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: The signaling mechanism of Hcy-induced atrial fibrosis mediated by TRPC3</h4><p><a href="https://www.biorxiv.org/content/10.1101/583740v1">Link</a></p><p><b>Date:</b> 2019-03-20</p><p><b>Authors:</b> Lu Han ... Juxiang Li</p><p><b>Downloads:</b> 158</p></div><div class="everything-else"><p><b>Abstract:</b> Background: High plasma levels of homocysteine (Hcy) are regarded as a risk factor for atrial fibrillation (AF), which is closely associated with the pathological consequence of atrial fibrosis and can lead to heart failure with a high mortality rate; Currently, there is no effective therapy for preventing atrial fibrosis, owing to a lack in fundamental understanding of the underlying mechanism.  Here, we show that atrial fibrosis is mediated by the relationship between canonical transient receptor potential 3 (TRPC3) channels and sirtuin type 1 (SIRT1) under the stimulation of Hcy.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31871214">Link</a></p><p><b>Date:</b> 2019-12-24</p><p><b>Authors:</b> David T Paik ...  Joseph C Wu</p><p><b>IF (7 or above):</b> 19.51</p></div><div class="everything-else"><p><b>Abstract:</b> Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for regenerative therapy, disease modeling, and drug discovery.  iPSCs allow for the production of limitless supply of patient-specific somatic cells that enable advancement in cardiovascular precision medicine.</p></div></td></tr><tr><td><div class="everything-else"><h4 class="title">Title: Animal model and therapeutic prospects for left ventricular hypertrophy and associated renal complication</h4><p><a href="https://www.biorxiv.org/content/10.1101/638353v1">Link</a></p><p><b>Date:</b> 2019-05-14</p><p><b>Authors:</b> Ashfaq Ahmad ... Raheel Qamar</p><p><b>Downloads:</b> 136</p></div><div class="everything-else"><p><b>Abstract:</b> Cardiac and renal dysfunction often co-occur and considerably worsen the prognosis leading to difficulty in therapy in left ventricular hypertrophy (LVH).  The aim of this study was to elucidate changes in expression of human ortholog genes of hypertension, vascular and cardiac remodeling and hypertensive nephropathy phenotypes under normal, disease and gasotransmitter, H2S (hydrogen sulphide) and NO (nitric oxide) and combined (H2S+NO), treatment of rat myocardium and renal tissues.</p></div></td><td><div class="everything-else"><h4 class="title">Title: Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32064346">Link</a></p><p><b>Date:</b> 2020-02-17</p><p><b>Authors:</b> Xiao Ma ...  Xiaolei Xu</p><p><b>IF (7 or above):</b> 12.53</p></div><div class="everything-else"><p><b>Abstract:</b> To uncover the genetic basis of anthracycline-induced cardiotoxicity (AIC), we recently established a genetic suppressor screening strategy in zebrafish.  Here, we report the molecular and cellular nature of .</p></div></td></tr><tr><td></td><td><div class="everything-else"><h4 class="title">Title: IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32034154">Link</a></p><p><b>Date:</b> 2020-02-08</p><p><b>Authors:</b> Sissy E Wamaitha ...  Kathy K Niakan</p><p><b>IF (7 or above):</b> 11.8</p></div><div class="everything-else"><p><b>Abstract:</b> Our understanding of the signalling pathways regulating early human development is limited, despite their fundamental biological importance.  Here, we mine transcriptomics datasets to investigate signalling in the human embryo and identify expression for the insulin and insulin growth factor 1 (IGF1 ....</p></div></td></tr><tr><td></td><td><div class="everything-else"><h4 class="title">Title: Roles of circRNAs in the tumour microenvironment.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31973726">Link</a></p><p><b>Date:</b> 2020-01-24</p><p><b>Authors:</b> Qiuge Zhang ...  Zhenqiang Sun</p><p><b>IF (7 or above):</b> 11.35</p></div><div class="everything-else"><p><b>Abstract:</b> The tumour microenvironment (TME) constitutes the area surrounding the tumour during its development and has been demonstrated to play roles in cancer-related diseases through crosstalk with tumour cells.  Circular RNAs (circRNAs) are a subpopulation of endogenous noncoding RNAs (ncRNAs) that are ub ....</p></div></td></tr><tr><td></td><td><div class="everything-else"><h4 class="title">Title: Myopathy reversion in mice after restauration of mitochondrial complex I.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31916679">Link</a></p><p><b>Date:</b> 2020-01-09</p><p><b>Authors:</b> Claudia V Pereira ...  Carlos T Moraes</p><p><b>IF (7 or above):</b> 10.28</p></div><div class="everything-else"><p><b>Abstract:</b> Myopathies are common manifestations of mitochondrial diseases.  To investigate whether gene replacement can be used as an effective strategy to treat or cure mitochondrial myopathies, we have generated a complex I conditional knockout mouse model lacking NDUFS3 subunit in skeletal muscle.</p></div></td></tr></table></div><hr></div></body></html>